CJC-1295 combined with Ipamorelin is the most widely used growth hormone secretagogue stack in clinical practice. It's the protocol serious athletes, biohackers, and longevity-focused patients turn to when they want to optimize body composition, accelerate recovery, and improve sleep quality — without the risks and regulatory complexity of exogenous HGH.
This guide covers exactly what CJC-1295 and Ipamorelin are, how they work together, the complete dosing protocol, what to expect, and why they outperform HGH as a therapeutic approach.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) — the hormone your hypothalamus uses to signal the pituitary to produce and secrete HGH. The "DAC" version (Drug Affinity Complex) extends its half-life to approximately 6–8 days through albumin binding, producing a sustained elevation in growth hormone levels with just 1–2 injections per week.
It does not directly introduce HGH into the body. Instead, it stimulates your own pituitary gland to produce and release more of your natural growth hormone — preserving the pulsatile secretion pattern that makes GH therapeutically effective and safe.
Ipamorelin is a GHRP (growth hormone-releasing peptide) — specifically, a selective ghrelin receptor agonist. While CJC-1295 stimulates the GHRH pathway, Ipamorelin activates a completely different pathway (the ghrelin/GHS-R1a receptor) to trigger pituitary GH release. Together, the two compounds create a powerful synergistic effect: each stimulates a different mechanism for GH secretion, and their combined effect is significantly greater than either alone.
The GHRH + GHRP combination is sometimes called the "two-step key" — GHRH (CJC-1295) primes the pituitary for a large GH pulse, and the GHRP (Ipamorelin) triggers the release. Research shows the combined effect produces GH pulses 2–10x greater than either peptide alone.
Ipamorelin has the cleanest side effect profile of any GHRP — unlike GHRP-2 or GHRP-6, it does not significantly increase cortisol, prolactin, or appetite. This makes the CJC-1295/Ipamorelin combination the first choice for most clinical protocols.
| Parameter | Standard Protocol | Advanced Protocol |
|---|---|---|
| Formulation | CJC-1295/Ipamorelin 2-2MG/ML (5ML) | CJC-1295/Ipamorelin 2-2MG/ML + IGF-LR3 |
| Dose per injection | 0.1–0.2mL (200–400mcg each) | 0.2mL (400mcg each) |
| Frequency | 5 nights/week (before bed) | 5 nights + 1 AM dose on training days |
| Timing | 30–60 min before sleep, fasted | 30 min pre-sleep; AM 30 min post-workout |
| Cycle length | 3–6 months on, 1–2 months off | Continuous (with physician monitoring) |
| Verum Price | $200 / 5ML vial | $200 + $290 (IGF-LR3) |
Critical timing note: GH secretion is strongly inhibited by elevated blood glucose and insulin. Injections should always be administered in a fasted state — at least 2–3 hours after your last meal. The best window is immediately before bed, which also syncs with the natural nocturnal GH pulse.
| Factor | CJC-1295/Ipamorelin | Direct HGH |
|---|---|---|
| GH secretion pattern | Natural pulsatile | Supraphysiological, flat |
| IGF-1 elevation | Moderate, controlled | Often supraphysiological |
| Pituitary feedback | Preserved | Suppressed over time |
| Side effect profile | Mild (water retention possible) | Carpal tunnel, acromegaly risk |
| Cost | $200/vial | $800–$2,000+/month |
| Prescription | Required | Required (Schedule III) |
Contraindications include active malignancy, pregnancy, and certain pituitary conditions. Your physician will evaluate your complete health history during the intake process.
Sleep improvement is typically the first effect, appearing within the first 1–2 weeks. Body composition changes require 8–12 weeks of consistent use to become noticeable. Full benefits emerge at the 3–6 month mark.
Standard protocol is 3–6 months on, followed by a 1–2 month break to maintain pituitary sensitivity. Some physicians prescribe continuous use with periodic monitoring — this is determined case by case.
CJC-1295 with DAC has a half-life of ~6–8 days due to albumin binding. CJC without DAC (Modified GRF 1-29) has a short half-life of ~30 minutes, requiring more frequent dosing. Verum Health uses the CJC-1295 with DAC formulation for clinical convenience and consistent GH elevation.
Yes. CJC-1295/Ipamorelin is commonly stacked with BPC-157 (recovery), NAD+ (cellular energy), and for fat loss patients, semaglutide or AOD-9604. Your physician will build a stack appropriate for your goals and health profile.
Disclaimer: These statements have not been evaluated by the FDA. Prescription required. Individual results may vary. This article is informational only and does not constitute medical advice.
The gold-standard GH secretagogue stack. Physician-reviewed, pharmacy-dispensed.